MedPath

Effect of Gel with Middle Aemniotic Formulation in Diabetic Foot Ulcers

Phase 2
Recruiting
Conditions
.
Registration Number
IRCT20201010048985N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
92
Inclusion Criteria

Since the Wound was Made has Passed More than a Year
The Wound Must be in the Foot Area

Exclusion Criteria

The wound is in an area except the foot

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Healing Diabetic Foot Ulcers. Timepoint: From the Beginning of the Study Uuntil 8 Weeks after the Start Date of the Intervention. Method of measurement: Use a Diabetic Foot Wound Healing Checklist.
Secondary Outcome Measures
NameTimeMethod
Diabetic Foot Wound Healing. Timepoint: From the Beginning of the Study until 8 Weeks after the Start Date of the Intervention. Method of measurement: Diabetic Foot Ulcer Checklist.;Diabetic Foot Ulcer Discharge. Timepoint: From the Beginning of the Study until 8 Weeks after the Start Date of the Intervention. Method of measurement: Diabetic Foot Ulcer Checklist.;Diabetic Foot Ulcer Around Tissues. Timepoint: From the Beginning of the Study until 8 Weeks after the Start Date of the Intervention. Method of measurement: Diabetic Foot Ulcer Checklist.;Diabetic Foot Ulcer Color. Timepoint: From the Beginning of the Study until 8 Weeks after the Start Date of the Intervention. Method of measurement: Diabetic Foot Ulcer Checklist.;Diabetic Foot Ulcer Degree. Timepoint: From the Beginning of the Study until 8 Weeks after the Start Date of the Intervention. Method of measurement: Diabetic Foot Ulcer Checklist.
© Copyright 2025. All Rights Reserved by MedPath